摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-2-甲基苯甲醛 | 24078-12-4

中文名称
4-溴-2-甲基苯甲醛
中文别名
2-甲基-4-溴苯甲醛
英文名称
4-bromo-2-methylbenzaldehyde
英文别名
2-methyl-4-bromobenzaldehyde
4-溴-2-甲基苯甲醛化学式
CAS
24078-12-4
化学式
C8H7BrO
mdl
MFCD07787171
分子量
199.047
InChiKey
RCBPVESMGNZMSG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    115-116 °C(Press: 8 Torr)
  • 密度:
    1.490±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2913000090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温。

SDS

SDS:b006f80decd52a483868055e04b0cb1d
查看
Material Safety Data Sheet

Section 1. Identification of the substance
4-Bromo-2-methylbenzaldehyde
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
4-Bromo-2-methylbenzaldehyde
Ingredient name:
CAS number: 24078-12-4

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H7BrO
Molecular weight: 199.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质

4-溴-2-甲基苯甲醛中的溴原子可在过渡属催化下与芳基硼酸类化合物发生Suzuki偶联反应;同时,其醛基单元可与格式试剂或有机锂试剂进行亲核加成反应。

用途

由于具有丰富的化学转化性质,4-溴-2-甲基苯甲醛可用作有机合成中间体,例如用于制备黄体酮受体调节剂。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    134.试图寻找新的化学am。第七部分
    摘要:
    DOI:
    10.1039/jr9470000690
  • 作为产物:
    描述:
    4-溴-2-甲基苯腈二异丁基氢化铝 作用下, 以 正己烷 为溶剂, 反应 1.5h, 生成 4-溴-2-甲基苯甲醛
    参考文献:
    名称:
    作为阿片样物质受体的拮抗剂或反向激动剂的 新型化合物
    摘要:
    本发明涉及作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物。本发明提供作为一种或多种阿片样物质受体上的拮抗剂或反向激动剂的新型化合物、含有该新化合物的药物组合物及它们的制备方法。
    公开号:
    CN102516115B
  • 作为试剂:
    描述:
    (4-溴-2-甲基苯基)甲醇 、 、 methyl 1-({5-[5-(3-fluoro-4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-4-methyl-2-thienyl}methyl)azetidine-3-carboxylate 在 4-溴-2-甲基苯甲醛 、 crude product 作用下, 生成 、 4-溴-2-甲基苯甲醛
    参考文献:
    名称:
    Heterocyclic compound
    摘要:
    具有低毒性的免疫抑制活性化合物或其药物盐。该化合物具有下面所示的一般式(I)或其药理学上可接受的盐或药理学上可接受的前药。
    公开号:
    US07687491B2
点击查看最新优质反应信息

文献信息

  • Iridium-Catalyzed <i>ortho</i>-C(sp<sup>2</sup>)–H Amidation of Benzaldehydes with Organic Azides
    作者:Delong Mu、Xinmou Wang、Gong Chen、Gang He
    DOI:10.1021/acs.joc.7b00531
    日期:2017.4.21
    ortho-C(sp2)–H amidation reaction of benzaldehydes with organic azides has been developed. A catalytic amount of 3,5-di(trifluoromethyl)aniline was used to promote the Ir-catalyzed directed C–H amination reaction through a transient aldimine intermediate. This reaction tolerates a broad scope of benzaldehyde substrates and works well with a range of aryl- and alkylsulfonyl azides.
    已开发出催化的苯甲醛与有机叠氮化物的邻位C(sp 2)-H酰胺化反应。催化量的3,5-二(三甲基)苯胺用于通过短暂的亚胺中间体促进Ir催化的直接CH胺化反应。该反应可耐受各种范围的苯甲醛底物,并能与多种芳基和烷基磺酰基叠氮化物一起很好地起作用。
  • [EN] CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME<br/>[FR] COMPOSÉS CARBAMATES ET LEUR PROCÉDÉ DE FABRICATION ET D'UTILISATION
    申请人:ABIDE THERAPEUTICS
    公开号:WO2013142307A1
    公开(公告)日:2013-09-26
    Provided herein are carbamate compounds which may be useful in the treatment of, for example, pain, solid tumors and/or obesity.
    本文提供的是可能在治疗疼痛、实体肿瘤和/或肥胖等方面有用的氨基甲酸酯化合物。
  • [EN] PYRAZOLE MAGL INHIBITORS<br/>[FR] INHIBITEURS PYRAZOLE DE MAGL
    申请人:ABIDE THERAPEUTICS INC
    公开号:WO2018217805A1
    公开(公告)日:2018-11-29
    Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of monoacylglycerol lipase (MAGL). Furthermore, the subject compounds and compositions are useful for the treatment of pain.
    本文提供了吡唑化合物和包含该化合物的药物组合物。这些化合物和组合物可用作单酰基甘油酶(MAGL)的调节剂。此外,这些化合物和组合物可用于治疗疼痛。
  • Generation of Phosphoranyl Radicals via Photoredox Catalysis Enables Voltage–Independent Activation of Strong C–O Bonds
    作者:Erin E. Stache、Alyssa B. Ertel、Tomislav Rovis、Abigail G. Doyle
    DOI:10.1021/acscatal.8b03592
    日期:2018.12.7
    oxygen-centered nucleophile. We show the desired reactivity in the reduction of benzylic alcohols to the corresponding benzyl radicals with terminal H atom trapping to afford the deoxygenated products. Using the same method, we demonstrate access to synthetically versatile acyl radicals, which enables the reduction of aromatic and aliphatic carboxylic acids to the corresponding aldehydes with exceptional chemoselectivity
    尽管醇和羧酸作为有机分子中的官能团盛行,并且有可能用作自由基前体,但C-O键仍然难以激活。我们报告了通过光氧化还原催化直接从这些普遍存在的官能团同时进入烷基和酰基自由基的合成策略。该方法利用了磷化氢自由基的独特反应性,该反应是由膦自由基阳离子和以氧为中心的亲核试剂之间的极性/ SET交叉产生的。我们显示了在末端醇被俘获以提供脱氧产物的情况下,将苄醇还原为相应的苄基所需要的反应性。使用相同的方法,我们演示了合成通用的酰基自由基的获得方法,可以将芳香族和脂肪族羧酸还原为相应的醛,并具有出色的化学选择性。该协议还通过分子内酰基自由基环化将羧酸转化为杂环和环状酮,从而一步一步形成C–O,C–N和C–C键。
  • NOVEL S1P RECEPTOR MODULATING AGENT
    申请人:MEIJI SEIKA PHARMA CO., LTD.
    公开号:US20130217663A1
    公开(公告)日:2013-08-22
    An object of the present invention is to provide a compound having a modulating activity at an S1P receptor which is useful for preventing and treating autoimmune diseases, allergic diseases, and the like. According to the present invention, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof is provided.
    本发明的一个目的是提供一种具有S1P受体调节活性的化合物,该化合物对于预防和治疗自身免疫疾病、过敏性疾病等是有用的。根据本发明,提供了一种由式(I)表示的化合物或其药学上可接受的盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫